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Physiologic hypertrophy occurs as the result of exercise conditioning and is characterized bv normal or
" supranormal left ventricular (LV) contractile function and reversibility of structural alterations. Whether
hypertrophy produced by chronic abnormal loading can be termed 'physiologic' is a matter of debate because in
experimental pressure overload hypertrophy normal in vivo ventricular function may be associated with abnormal
I in vitro function of the papillary muscles. In patients with moderate LV hypertrophy from aortic valve disease
(angiographic mass < 180 g/m2) ejection fraction (EF) is preserved, but at similar levels ofafterload, when mass
-* exceeds 180 g/m2, EF is depressed. Comparison of LV function with myocardial structure (endomyocardial
biopsies) has shown that in patients with compensated LV function and those with left heart failure (EF <57°/o.
LVEDP > 20mm Hg and/or cardiac index < 2-5 l/min/m2) interstitialfibrosis (IF) was increased to a similar
f extent (16 and 18%: normal < 5%), whereas muscle fiber diameter (MFD; normal < 20 /<) was larger (P < 005)
i in the patients with failure (30 /J.) than in those with preserved function (27 n). Moreover patients with depressed
postoperative function had a larger (P < 001) preoperative MFD (35 /() than those with normal postoperative
a function (30 ft). Seventeen months after successful aortic valve replacement IF increased (P < 002) and MFD
decreased (P < 0001) but did not become normal regardless whether postoperative function was normal or
" \ depressed. Thus in secondary hypertrophy myocardial structure is pathologic even in the presence of normal LV
function and depressed function appears likely to be related to excessive fiber hypertrophy rather than to IF.
*" Massive fiber hypertrophy heralds an unfavorable postoperative L V function and fibrosis is irreversible after
L surgical correction of the abnormal load.
The predominant compensatory mechanism in alterations which may have occurred during the
conditions with chronic abnormal loading of the formation of hypertrophy following the elimination
heart is myocardial hypertrophy. When an increase in of the stimulus to hypertrophy. Conversely in
muscle mass is associated with normal or enhanced pathological hypertrophy there is no or only
myocardial function, hypertrophy is termed physio- incomplete reversibility of morphological alterations.
** logical"1. Biochemically, physiological hypertrophy
„ , is characterized by a normal or increased myosin ™ • • • • . L I . I L
 L , L
• . _ „ . . ,,, , , , . . . Physiological and pathological hypertrophy in theATPase activity . In contrast, pathological hyper- . . . .
, . , • . . • • j J I experimental animali trophy is determined by impaired myocardial r
function and a decreased myosin ATPase activity1". The prototype of physiological hypertrophy is the
These definitions do not take into account the hypertrophy consequent to exercise conditioning.
I potentials of reversibility of hypertrophy. As will be Myocardial function has been demonstrated to be
shown later in this paper, it seems appropriate to add increased in isolated hearts from rats with increased
> •* to the characteristics of physiological hypertrophy heart weight/body weight ratio after training by
the capacity of full reversibility of any myocardial swimming121 and in intact dogs trained by treadmill
i running131 as compared to function in cor-
sequesis for rtprims w H. P• Krayenbuehl. M c'•• Ch.ef or
 r e s p o n d i n g sedentary animals. However, in vitro
™ Cardiology, Medical Policlinic of Ihe University. CH-8091 Zurich. F 6 J '
Switzerland studies carried out in papillary muscles of trained cats
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did not elicit a higher than normal contractile
state'41. The diastolic properties of the left ventricle
evaluated by the diastolic pressure-length relation-
ship have been found to be normal in trained
dogs<3). Cardiac myosin ATPase activity is typically
increased in exercise-conditioned animals as shown
by several studies summarized in the overview by
Scheuer and Bhan|6). There is excellent reversibility
of exercise-induced hypertrophy because in the
myocardium of rats two weeks following cessation of
training, the structural alterations typical of hyper-
trophy regressed substantially and the light micro-
scopic picture was almost indistinguishable from that
of normal rats'7'.
Of importance is the question of whether a chronic
abnormal mechanical burden by pressure or volume
overload leads to physiological or pathological
hypertrophy. Most ' 8"" 1 but not all"21 animal
models with chronic volume overload did show
essentially normal in vivo and in vitro function of the
hypertrophied myocardium. In contrast myocardial
hypertrophy consequent to the production of severe
pressure overload with sudden onset was associated
with depressed contractility"3"1" which sometimes
improved with time although the pressure loading
persisted"6'. These pressure overload models have
however little analogy to the more progressive
development of pressure loading in man. Hence only
models in which a gradually increasing pressure load
was applied are considered in the present discussion.
Progressive pressure loading was achieved by a slight
banding of either the aorta or the pulmonary artery in
young animals"7 '"'. With normal growth of the
animal a considerable stenosis developed and
myocardial hypertrophy ensued. In dogs"7 ' and in
cats"8 ' the ejection fraction of the overloaded
ventricle remained within normal limits 37 and 60
weeks respectively after banding. No consistent
findings were obtained in vitro. In the cat papillary
muscle Cooper et a/."81 found a decrease in
maximal velocity of shortening and maximal active
isometric tension with increasing duration of pressure
loading (25-60 weeks), whereas with a similar
duration (24-52 weeks) of progressive pressure
loading Williams el a/."9' could demonstrate no
change in contractility. This difference can probably
be explained by the fact that in the study of Cooper et
a/."81 the hydroxyproline concentration was signifi-
cantly increased in the hypertrophied muscle, whereas
it was similar in banded and non-banded animals in
the study of Williams et a/."9'. Thus the connective
tissue content is likely to have been more marked in
the former"81 animals and may have interfered with
normal contractile behavior. Furthermore, an
increased hydroxyproline content has been shown not
to decrease after debanding in rats with left
ventricular hypertrophy from constriction of the
ascending aorta'20'.
In summary these studies in animals with
progressive pressure load indicate that despite
preserved pump function in vitro muscle function can
be depressed and probably irreversible increase in
connective fibrous tissue may occur. Hence the
apparent physiological hypertrophy as judged from
the normal pump function is in fact already an early
form of pathological hypertrophy.
Nature of secondary hypertrophy in man. Systolic
function and relaxation
In contrast to the studies in the papillary muscles,
where an unequivocal assessment of contractility is
possible, the evaluation of contractility in man is
complicated by the fact that there is no contractile
index which is not influenced by either afterload,
preload or heart rate. Recently we have studied by
left ventricular (LV) micromanometry and cineangio-
graphy 47 patients with aortic valve disease before
and 18 months after successful valve replacement. LV
contractile state was assessed by the relationship
between ejection fraction (EF) and peak systolic
circumferential wall stress (PSWS)'2" (Fig. 1) and
by a function diagram where LV isovolumic maximal
rate of rise of circumferential wall stress (max d<r/dt)
was plotted v. end-diastolic wall stress (EDS)'221
(Figs 2 and 3). Patients with mild to moderate LV
hypertrophy having an angiographic mass
< 180 g/m2 (GR 1) and patients with severe
hypertrophy in whom mass was 5= 180 g/m2 (GR 2)
were analyzed separately. Moreover, the patients
were divided in those with pure or predominant
aortic stenosis (AS, n = 27) and those with pure
or predominant aortic insufficiency (AI, n = 20).
Fourteen control patients (C) were studied by the
same techniques. At the preoperative evaluation the
GR 1 (AS and AI) as well as the GR 2 (AS and AI)
patients had a significantly increased PSWS as
compared to C (Fig. I). No difference existed among
the four groups with aortic valve disease. The GR 2
patients with severe hypertrophy showed however a
significantly lower EF than the GR 1 patients which
was indicative of depressed contractility. In turn the
EF in the GR 1 patients was only slightly and
insignificantly smaller than in C. This mildly
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Figure I Relation between left ventricular (LV) ejection
fraction (EF) and peak systolic circumferential wall stress
(PSWS) in 14 controls (C), 17 patients with aortic stenosis
(AS) and an LV angiographic mass (LMMI) < 180 g/m2
(AS GR 1) ( • ) , 10 patients with AS and an LMMI
£180 g/m2 (AS GR 2) (O), 10 patients with aortic
insufficiency (Al) and an LMMI < 180 g/m2 (AI GR 1) (A)
and 10 patients with AI and an LMMI > 180 g/m2 (AI GR
2) (A)- Mean values + 1 standard error are presented. The
arrows are directed from the preoperative to the
postoperative values. At the preoperative evaluation PSWS
was increased significantly in all patients groups as
compared to the C (asterisks to the right of the symbols). In
both patient groups having an LMMI < 180 g/m2 EF was
slightly and insignificantly decreased probably consequent
to the increased PSWS (afterload). In contrast, both patient
groups with severe hypertrophy (LMMI > 180 g/m2)
elicited a significantly decreased EF at similar PSWS to the
GR I patients indicative of depressed LV contractile
function (asterisks above the symbols for comparison with
C). *, P< 0 05, •*, P - 0 02, *•*, P - 0 0 1 ; * * " ,
P < 0-001) Following successful aortic valve replacement
the relation between EF and PSWS became normal (not
different from C) except in the patients with AI and severe
preoperative hypertrophy whose EF remained depressed
despite normalization of PSWS.
decreased EF was probably due to the increased
afterload at an apparently unchanged contractile
state. From Fig. 2 it is however evident that a
beginning depression of contractile state was also
present in the GR 1 patients, because the AS group
and especially the AI group were located rightward
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Figure 2 Left ventricular function diagram opposing iso-
volumic maximal rate of rise of circumferential wall stress
(max d<x/dt, ordinate) to circumferential end-diastolic wall
stress (EDS, abscissa) in the control group (C) and in the
patients with aortic stenosis ( • . preoperatively; O-
postoperatively) and aortic insufficiency (A, preoperatively;
A . postoperatively) having an LMMI < 180 g/m2. Pre-
operatively the relationship between maximum dff/dt and
EDS was located rightward and downward to the control
group indicating an impaired contractile state. After surgery
the relationship between max du/dt and EDS became
normal (not different from C). Mean values ± 1 standard
error are presented. Asterisks to the right of the symbols are
for comparison of EDS and above the symbols for
comparison of max du/dt. *, P < 005 ; **. P < 002; *•*,
P < 001 (unpaired t-test).
and downward to the control group eliciting less
isovolumic performance at an increased preload. An
even more marked rightward and downward shift
was observed in the GR 2 patients (Fig. 3).
Following surgery the relationship between EF and
PSWS and maximum dcr/dt and EDS respectively
became normal in the GR 1 patients and in the GR 2
patients with preoperative AS (Figs 1-3). In contrast
the GR 2 patients with preoperative AI elicited no
normalization of the EF despite a postoperative
PSWS close to that of the controls (Fig. 1). Preload
also became normal in AI GR 2 but max dff/dt
remained depressed (Fig. 3).
From these observations one can conclude that in
AI with severe increase of angiographic mass there is
pathological hypertrophy with at best partial
reversibility of depressed function after surgery-
Although all the AS patients and the AI GR 1
patients elicited a postoperative contractile function
not different from that in C they probably do not
represent groups with true physiological hypertrophy
because there were clear-cut (AS GR 2) or beginning
functional deficits (AS GR 1. AI GR 1) prior to
surgery.
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Figure 3 Left ventricular function diagram opposing
isovolumic maximal rate of rise of circumferential wall stress
(max dff/dt) to circumferential end-diastolic wall stress
(EDS) in the control group ( Q and in the patients with
aortic stenosis and insufficiency having an LMMI
>180g/m2 . Preoperatively the relationship between max
dtr/dt and EDS was shifted rightward and downward to the
control group indicating an impaired contractile state. The
shift was clearly more marked in the patients with AI than in
those with AS. Moreover the shift was greater than in the
patients with an LMMI < 180 g/m2 (vide Fig. 2). After
surgery the relationship between max du/dt and EDS
became practically normal in the patients with AS whereas
in the putients with AI max d<r/dt remained significantly
depressed. Symbols as in Fig. 2.
A further argument that even patients with well
compensated pump function having a normal LV
ejection fraction may not have true physiological, but
rather beginning pathological hypertrophy stems
from studies on the LV pressure decay (time constant,
T) during isometric exercise1231. In 14 patients with
aortic valve disease having a LV EF not different
from control subjects T was significantly (P < 0-05)
greater (60 ms) than in 12 controls (38 ms). Because
the prolonged T in the patients with aortic valve
disease may solely be the consequence of the
increased LV peak systolic pressure'241 and the
hypertrophy of the left heart chamber per se12^ and
may therefore not be indicative of an intrinsic
relaxation disturbance the reaction of T to an
additional load produced by handgrip was evaluated.
It was found (Fig. 4) that, unlike in the controls who
showed a decrease of T during handgrip, T did not
change in the patients with aortic valve disease. The
systolic response to handgrip evaluated by the change
of LV end-diastolic pressure and peak measured
velocity of the contractile elements did not differ
between the patients with aortic valve disease and the
controls.
From these observations it was concluded that in
patients with aortic valve disease and normal ejection
Figure 4 Time constant of LV pressure decay (T) in (a) 12
control subjects and (b) 14 patients with aortic valve disease
(AVD) at rest (C) and during handgrip (HG, 3 min at 30%
of maximal voluntary contraction). The reaction to HG was
different in the two groups because T decreased in the
controls but remained unchanged in AVD. P = probability
(paired t-test); NS = not significant
performance the reaction of LV relaxation to
handgrip is abnormal despite a normal contractile
response and is likely to represent an early sign of
impaired myocardial function.
Correlations between function and structure in
secondary hypertrophy
In recent years the morphometric analysis of
endomyocardial .biopsies taken at cathetenzation or
of biopsies obtained at surgery has added con-
siderably to our concept of the nature of hypertrophy
in man. In patients with aortic valve disease it has
been shown, that already in the stage of compensated
LV function there is marked increase in interstitial
fibrosis'26 ~29'. In 51 patients (24 aortic stenosis,
nine aortic insufficiency, 18 combined lesion) with
preserved LV function (biplane EF ^ 57%, LV
end-diastolic pressure ^ 20 mm Hg, cardiac index
> 2-5 1/min/m2) we have found interstitial fibrosis to
be increased to 16% (normal < 5%) l 2 9 '. The mean
muscle fiber diameter (MFD) amounted to 27//
(normal ^20/ ; ) - ' n 20 patients with aortic valve
disease (11 aortic stenosis, six aortic insufficiency,
three combined lesion) presenting with left heart
failure (EF < 57%, LV end-diastolic pressure
> 2 0 m m H g and/or cardiac index < 2-5 1/min/m2)
the interstitial fibrosis was only insignificantly higher
1
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(18%) than in the group with compensated LV
function, but MFD was increased (P < 005) to 30 /*.
Massive cellular hypertrophy has also been shown
to be indicative of persistent postoperative LV
dysfunction12830'. In 20 patients with aortic valve
disease LV endomyocardial biopsies were obtained
preoperatively as well as 17 months after successful
aortic valve replacement. Eight of these patients had
a depressed LV ejection fraction after surgery.
Preoperative MFD was 35 n in this group whereas in
the 12 patients with normal postoperative ejection
fraction preoperative MFD was 30 ft (P < 001) (Fig.
5). Hence it does appear that advanced cellular
hypertrophy rather than excessive interstitial fibrosis
is at the origin of depressed contractile function. In
this context it is also noteworthy that Schwarz et
al.ai) found a reduction of myofibrils with respect
to the cell volume in patients with decompensated
pressure overload from aortic stenosis. They
speculated that this deficit of myofibrils might be the
cause for the depressed contractile quality of the LV
£
40
30
20 -
I 0 -
(a)
•in
f 30
20
I 0
(b)
1<OO5-
<0'0l
GRI
<OO2
GR2
1
-<005J 1<OO9J
' MS 1
GRI GR2
Figure 5 (a) Muscle fiber diameter (MFD) and (b)
interstitial fibrosis (IF) in 12 patients with aortic valve
disease and normal (^ 57%) postoperative left ventricular
biplane ejection fraction (EFpo) (GR 1) and 8 patients with
aortic valve disease and depressed (< 57%) EF r o (GR 2).
The bars to the left indicate the preoperative and the bars to
the right the postoperative values. In both groups MFD
decreased after surgery. However, GR 2 patients with
depressed postoperative ventricular function had a signifi-
cantly larger preoperative MFD than did GRI patients with
normal postoperative function. In both groups IF increased
significantly after surgery. There were, however, no
significant differences between the two groups neither before
nor after surgery. The horizontal dashed lines indicate the
upper limit of normality for both MFD and IF. P values
were obtained by the paired or the unpaired t-test as
appropriate; NS = not significant.
myocardium. In turn, massive interstitial fibrosis
appears to play a major role in altering the passive
diastolic properties of the myocardium1311.
Reversibility of cellular hypertrophy after aortic
valve replacement was incomplete in both patients
with normal and depressed postoperative LV
function (Fig. 5). The upper limit of normality of the
MFD was reached in no instance despite the fact that
LV angiographic mass decreased to normal values in
almost 70% of the patients'281. Interstitial fibrosis
increased significantly (P < 002) from 17 to 26°O in
the 20 patients as a group as well as in the two
subgroups with normal and depressed postoperative
LV function (Fig. 5). LV fibrous content (°0
interstitial fibrosis x angiographic mass) remained
unchanged (preoperative 29 g/m2, postoperative
28 g/m2).
In summary the bulk of functional and morpho-
logical data suggests that secondary hypertrophy in
patients with aortic valve disease is not a physio-
logical adaptation but a pathological process
because:
(1) even in moderate hypertrophy when ejection
performance is preserved abnormalities of isovolumic
contraction as well as of relaxation are detectable;
(2) interstitial fibrosis is augmented not only in
patients with left heart failure, but also in those with
normal LV ejection fraction;
(3) reversibility of function, i.e. a normal ejection
fraction after surgery is not associated with
normalization of myocardial structure in that
interstitial fibrosis increases, fibrous content remains
the same and cellular hypertrophy regresses
incompletely.
From the experiments with trained animals it is
apparent that the occurrence of true physiological
hypertrophy is probably limited to exercise con-
ditioning. In secondary hypertrophy from chronic
mechanical loading various stages of severity of
pathological hypertrophy are possible.
This work was supported by a grant from the Swiss
National Science Foundation.
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